Shuning Ding
Shanghai Jiao Tong University
19 Papers
43 Citations
Shuning Ding is an academic researcher from Shanghai Jiao Tong University. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 6, co-authored 14 publications.
Chat about Author
Papers
Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes
Chih Wan Goh,Jiayi Wu,Shuning Ding,Caijin Lin,Xiaosong Chen,Ou Huang,Weiguo Chen,Yafen Li,Kunwei Shen,Li Zhu +9 more
TL;DR: Investigation of the clinicopathological characteristics and clinical outcomes of coexisting DCIS component in IDC and its clinical significance according to molecular subtypes found that patients with IDC/DCIS presented with more HER2 positive expression and might improve DFS in Her2 positive breast cancer.
Identification of a novel immune-related prognostic signature associated with tumor microenvironment for breast cancer.
TL;DR: Wang et al. as discussed by the authors developed a novel gene signature based on immune-related genes to improve the prognostic prediction of breast cancer. But, their work was limited to four immune related genes (CCL1, VGF, TSLP, FABP9).
Comparison of the Distribution Pattern of 21-Gene Recurrence Score between Mucinous Breast Cancer and Infiltrating Ductal Carcinoma in Chinese Population: A Retrospective Single-Center Study.
Jiayi Wu,Shuning Ding,Lin Lin,Xiaochun Fei,Caijin Lin,Lisa Andriani,Chihwan Goh,Jiahui Huang,Jin Hong,Weiqi Gao,Siji Zhu,Hui Wang,Ou Huang,Xiaosong Chen,Jianrong He,Yafen Li,Kunwei Shen,Weiguo Chen,Li Zhu +18 more
TL;DR: RS was significantly related to Ki-67 index and molecular subtypes in MC patients, which is similar in IDC patients, however, RS was not able to predict DFS and OS in patients with MC.
Abstract PO3-15-01: Overexpression of N-glycosylation related gene OST4 promotes chemotherapy resistance in triple-negative breast cancer
Wei Wang,Deyue Liu,Shuning Ding,Yan Fang,Jiayi Wu,Li Zhu +5 more
TL;DR: High OST4 expression promotes chemotherapy resistance in triple-negative breast cancer (TNBC) through N-glycosylation regulation, suggesting targeting OST4 may reverse drug-resistance and improve therapeutic effect in TNBC, a highly aggressive and treatment-resistant cancer subtype.